Skip to main content
. Author manuscript; available in PMC: 2019 Sep 7.
Published in final edited form as: N Engl J Med. 2019 Mar 7;380(10):905–914. doi: 10.1056/NEJMoa1810642

Table 2.

Medical Conditions Qualifying Patients for Inclusion in Trial.*

Principal Diagnosis Group Flexible Programs Standard Programs Difference in Change
Trial Year
(N-61,194)
Pretrial Year
(N = 60,757)
Trial Year
(N = 71,662)
Pretrial Year
(N = 70,972)
percent percentage points
Septicemia 18.3 17.2 18.0 16.7 −0.2
Congestive heart failure 13.0 12.7 12.5 12.4 0.2
Stroke 12.3 11.6 11.9 11.3 0.2
Acute myocardial infarction 9.3 9.5 7.9 7.5 −0.5
Coronary atherosclerosis 6.5 6.2 5.4 5.4 0.2
Gastrointestinal bleeding 5.7 5.7 6.3 6.4 0.1
Cardiac arrhythmia 5.7 6.5 5.1 5.6 −0.3
Renal failure 5.3 5.7 5.6 5.6 −0.4
Pneumonia 4.7 5.0 5.8 6.6 0.5
Chronic obstructive pulmonary disease, asthma, or bronchitis 3.9 4.5 5.2 5.5 −0.3
Pulmonary embolism 3.7 3.7 3.6 3.4 −0.2
Acute respiratory disorder 3.3 3.3 2.6 2.7 0.2
Cellulitis 2.6 2.6 3.4 3.4 <0.1
Syncope 1.9 2.0 2.3 2.5 0.1
Chest pain 1.5 1.6 1.6 1.8 0.1
Intestinal infection 1.2 1.3 1.5 1.8 0.2
Acute pancreatitis 1.1 1.0 1.2 1.2 0.0
*

Details regarding principal diagnosis codes in the International Classification of Diseases, 9th Revision (ICD-9) and ICD-10 are provided in Table S3 in the Supplementary Appendix. The t-test was used to assess the difference between the pretrial year and the trial year in the mean percentage of patients who had each qualifying condition within each group and to assess the between-group difference in the change between trial years.

P<0.01.

P<0.05.